GW PHARMACEUTICALS PLC Accounts Receivable
GW PHARMACEUTICALS PLC had Accounts Receivable of $84.95 million as of 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2021-05-03
- 2021-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $84.95M.
- 2020-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $71.17M.
- 2020-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $80.42M.
- 2020-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $80.36M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2021-03-31 | $84.95M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $71.17M 10-Q · filed 2021-05-03 |
| 2020-09-30 | $80.42M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $80.36M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $62.21M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $48.88M 10-K · filed 2021-02-26 |
| 2019-09-30 | $41.82M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $32.11M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $19.25M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $4.19M 10-K · filed 2020-02-27 |
| 2018-09-30 | $2.12M 10-KT · filed 2019-02-28 |
| 2017-09-30 | $1.37M 10-KT · filed 2019-02-28 |